Dr. Markus Otto is a Professor of Neurology and the Director of the Department of Neurology at the Martin-Luther-University Halle-Wittenberg in Germany. Dr. Otto has been working in biomarker research for neurodegenerative diseases for over 20 years. He has contributed to the development of new biomarkers and the implementation into clinical routine and standardization of sample collection for biobanking and clinical research. Examples include the routine determination of neurofilaments in cerebrospinal fluid (CSF) and blood for the diagnostic workup of ALS patients. Dr. Otto is a speaker of the German FTLD consortium and a co-founder of the International CSF Society bringing together leading experts in the field of biomarker research for neurological diseases.